HOME >> MEDICINE >> NEWS
Large families and animals keep allergies at bay

Having siblings, keeping a pet, or living on a farm helps protect infants against the development of atopic (allergic) diseases, but early infections increase the risk, according to new research from Denmark. This study will be available on bmj.com on Friday 30 May 2004.

Researchers conducted four separate interviews with over 24,000 pregnant women (twice during their pregnancy and again when their child was 6 and 18 months old).

Information on atopic dermatitis and infections before 6 months of age were recorded. Data on factors associated with exposure to microbes, such as number of siblings, pet keeping, living on a farm, and attending day care, were also collected.

The risk of atopic dermatitis increased with each infectious disease before 6 months of age. This contrasts with the common belief that infectious diseases early in life may protect against the development of allergic diseases.

However, the risk of atopic dermatitis decreased with each additional exposure to three or more siblings, day care, pet ownership, and farm residence. This protective effect remained after adjusting for number of infectious diseases, suggesting that it is established independently and very early in life, say the authors.

These findings support the importance of microbial exposure for preventing atopic dermatitis, but challenge the hypothesis that infectious diseases in infancy protect against its development, they conclude.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
29-Apr-2004


Page: 1

Related medicine news :

1. Large portion of late-stage breast cancers associated with absence of screening
2. Largest study of its kind finds male breast cancer on the rise
3. Large-scale analysis of women with androgen excess: thorough treatment can reduce symptoms
4. Largest multistate study finds end-of-life care still woefully inadequate
5. Largest study to date finds radiofrequency ablation is best treatment for benign bone tumor
6. Larger blood reserves needed for ageing population
7. Largest study of Hmong shamanism prompts new patient care guidelines
8. Largest ever study on European cancer prevalence shows large differences between countries
9. Largest ever overactive bladder study published in leading urology journal
10. Making kidney transplants last longer: Large UM study finds newer drug is better
11. Large-volume medical centers produce best clinical and economic results for complex gastrointestinal surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Large families and animals keep allergies bay

(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: